Results 211 to 220 of about 29,527 (256)

A Feasibility Assessment of the FDA Adverse Event Reporting System for the Detection of Cannabis-Related Safety Signals. [PDF]

Pharmacoepidemiol Drug Saf
Lopes POMV, Harris CS, Gravel CA.
europepmc   +1 more source

Differential Pulse Voltammetric Analysis of Cannabidiol on Fluorine-Doped Tin Oxide (FTO) Electrode Interface: Quantification in Pharmaceutical Oil with Assessment of Electrode Surface Stability. [PDF]

Sensors (Basel)
Romero M, Rocha Fontalvo E, Ospina-Castro ML, Arana VA, Meléndez CM, Vargas Álzate JA, Ramos-Hernández A.   +6 more
europepmc   +1 more source

Cannabidiol corrects sleep deficits and reduces spontaneous seizures in Angelman syndrome model mice. [PDF]

Neuropsychopharmacology
Shannon T, Najeeb M, Yi YJ, Shen Y, Gu B.   +4 more
europepmc   +1 more source

Tissue-specific untargeted ¹H-NMR metabolomics reveals no adverse metabolic effects of daily intrabuccal cannabidiol (CBD) in healthy mice. [PDF]

Front Pharmacol
Masiphephethu MV, Bhengu S, Venter K, Lemmer Y, Mason S.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cannabidiol

Reactions Weekly
Austin De La Cruz, Olajumoke Olateju, Dipali Rinker, Mina Shrestha, Douglas Thornton   +4 more
  +16 more sources